specifically, 300 mg three
times daily.8 Finally, the proportions of patients
who had an S. aureus isolate that was resistant to
clindamycin or TMP-SMX (5.2% and 0.2%, respectively)
were relatively low. Given the low prevalence
of resistance, its contribution to treatment
failure is unclear, although there was a trend
toward a lower clindamycin cure rate for infections
caused by clindamycin-resistant S. aureus versus
clindamycin-susceptible isolates (73.3% vs.
91.7%, P = 0.06), which also raises important questions
about the spontaneous response rate.
specifically, 300 mg threetimes daily.8 Finally, the proportions of patientswho had an S. aureus isolate that was resistant toclindamycin or TMP-SMX (5.2% and 0.2%, respectively)were relatively low. Given the low prevalenceof resistance, its contribution to treatmentfailure is unclear, although there was a trendtoward a lower clindamycin cure rate for infectionscaused by clindamycin-resistant S. aureus versusclindamycin-susceptible isolates (73.3% vs.91.7%, P = 0.06), which also raises important questionsabout the spontaneous response rate.
การแปล กรุณารอสักครู่..